Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
9.66
+0.46 (5.00%)
At close: Jan 9, 2026, 4:00 PM EST
9.43
-0.23 (-2.38%)
After-hours: Jan 9, 2026, 7:58 PM EST
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $9.04 million as of January 9, 2026. Its market cap has increased by 311.05% in one year.
Market Cap
9.04M
Enterprise Value
-8.24M
1-Year Change
311.05%
Ranking
Category
Stock Price
$9.66
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $131.30M to $9.04M, a decrease of -93.11%. That is a compound annual growth rate of -24.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 8.60M | -2.27% |
| Dec 31, 2025 | 8.80M | 300.00% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -73.77% |
| Dec 30, 2022 | 12.20M | -66.94% |
| Dec 31, 2021 | 36.90M | -75.47% |
| Dec 31, 2020 | 150.40M | 367.08% |
| Dec 31, 2019 | 32.20M | 2.88% |
| Dec 31, 2018 | 31.30M | -70.02% |
| Dec 29, 2017 | 104.40M | 161.00% |
| Dec 30, 2016 | 40.00M | -69.54% |
| Jul 20, 2016 | 131.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |